Cost-effectiveness Analysis of GAAD algorithm on Hepatocellular Carcinoma Screening in Patients with Chronic Hepatitis B in China

Home / Key Publications / Health Economics / Cost-effectiveness Analysis of GAAD algorithm on Hepatocellular Carcinoma Screening in Patients with Chronic Hepatitis B in China

You May Also Like

Advancing womens health key takeaways from AOGIN 2024 featured image

Key Publications

20 November 2024

Advancing women’s health: key takeaways from AOGIN 2024

Expert Opinions

19 November 2024

AOGIN Releases 2024 Position Statement for Cervical Cancer Screening

Expert Opinions

13 September 2024

Empowering Precision Oncology: Leveraging digital solutions to facilitate molecular tumour board meetings and patient care management

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.